Invesco Ltd. - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 166 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$12,012,656
-27.0%
1,027,601
-16.1%
0.00%
-25.0%
Q2 2023$16,458,813
-12.5%
1,224,614
+7.9%
0.00%
-20.0%
Q1 2023$18,815,780
-29.7%
1,134,848
-21.1%
0.01%
-37.5%
Q4 2022$26,750,539
+40.8%
1,438,201
-2.9%
0.01%
+33.3%
Q3 2022$19,000,000
+184.3%
1,480,909
+55.4%
0.01%
+200.0%
Q2 2022$6,682,000
+70.2%
953,262
+101.3%
0.00%
+100.0%
Q1 2022$3,925,000
+1502.0%
473,497
+1206.2%
0.00%
Q4 2021$245,000
+17.2%
36,250
-8.2%
0.00%
Q3 2021$209,000
+5.6%
39,481
+14.9%
0.00%
Q2 2021$198,000
+38.5%
34,362
+10.5%
0.00%
Q1 2021$143,000
+20.2%
31,105
-12.7%
0.00%
Q4 2020$119,000
+41.7%
35,620
+25.8%
0.00%
Q3 2020$84,000
-56.7%
28,316
-32.4%
0.00%
Q2 2020$194,000
+74.8%
41,910
+44.6%
0.00%
Q1 2020$111,000
+44.2%
28,984
+40.2%
0.00%
Q4 2019$77,000
-96.3%
20,673
-94.8%
0.00%
-100.0%
Q3 2019$2,094,000
+4173.5%
394,346
+1437.3%
0.00%
Q4 2018$49,000
-51.5%
25,652
-3.6%
0.00%
Q3 2018$101,000
+13.5%
26,598
-6.9%
0.00%
Q2 2018$89,000
-91.2%
28,558
-93.1%
0.00%
Q4 2015$1,014,000
-18.1%
413,770
+0.2%
0.00%
-100.0%
Q3 2015$1,238,000
+20533.3%
412,753
+29766.4%
0.00%
Q2 2015$6,000
-96.5%
1,382
-97.9%
0.00%
Q2 2014$171,00067,3930.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 589,883$590,0001.38%
Broadfin Capital, LLC 8,200,000$8,610,0000.96%
Avoro Capital Advisors LLC 1,141,149$1,198,0000.24%
CORRADO ADVISORS, LLC 190,600$200,0000.12%
Baker Brothers Advisors 5,102,153$5,357,0000.05%
KINGDON CAPITAL MANAGEMENT, L.L.C. 756,311$794,0000.04%
Point72 Asset Management, L.P. 2,272,816$2,386,0000.02%
AGRAN LIBBIE 44,000$46,0000.01%
COMPTON CAPITAL MANAGEMENT INC /RI 10,000$11,0000.01%
KENNEDY CAPITAL MANAGEMENT LLC 233,171$245,0000.00%
View complete list of CATALYST PHARMACEUTICALS INC shareholders